Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2016) 41 EP565 | DOI: 10.1530/endoabs.41.EP565

ECE2016 Eposter Presentations Diabetes therapy (44 abstracts)

The effect of diabetes on the duration and cost of treatment in patients with acute ischemic stroke

Baburhan Guldiken 1 , Merve Namli 1 , Burak Celik 1 , Mehmet Celik 2 , Buket Yilmaz Bulbul 2 & Sibel Guldiken 2


1Department of Neurology, Trakya University Medical Faculty, Edirne, Turkey; 2Department of Internal Medicine, Division of Endocrinology, Trakya University Medical Faculty, Edirne, Turkey.


Diabetes is an important risk factor for ischemic stroke. Hyperglycemia observed in acute ischemic stroke is accepted as a poor prognostic factor. In the present study, our aim is to investigate the effect of diabetes on the duration and cost of treatment in acute ischemic stroke.

Three hundred sixty two acute ischemic stroke patients that were hospitalized in the university neurology clinic in 2015 were retrospectively evaluated. Patients that have diabetes (n=112) were compared with the non-diabetics in respect to the duration and cost of hospitalization.

There were no significant difference among the age, gender and other vascular risk factors of both groups. We also found no difference between the duration (12.5±7.7, 10.9±7.2 days, respectively) and cost of hospitalization (743.5±588.2, 689.2±657.2 €, respectively).

The co-existence of diabetes does not bring additional load to the treatment cost of acute ischemic stroke that has self-high hospitalization costs due to theincreased mortality and morbidity.

Article tools

My recent searches

No recent searches.